重大事件
即時報告
8-K
2026-05-29
Rani Therapeutics提交8-K報告 披露股東投票事項但未提供細節
AI 繁中摘要
Rani Therapeutics Holdings, Inc.（CIK: 0001856725）於2026年5月29日向美國證監會提交了一份8-K現行報告 📄，報告日期為2026年5月28日。本次申報主要涉及項目5.07：將事項提交證券持有人表決（Submission of Matters to a Vote of Security Holders）。公司總部位於加州聖荷西，專注於藥物製劑領域（SIC 2834）。報告中並未披露具體的表決事項及投票結果細節，投資者需查閱附件或後續補充文件以了解股東投票的具體內容。對投資者而言，該8-K僅為程序性披露，短期內並未公佈重大財務或經營變動，市場影響有限。建議關注公司後續的10-Q或10-K申報以獲取更全面的業績與展望資訊 ⚖️。
展開英文正文
EDGAR Filing Documents for 0001193125-26-245636 SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 8-K - Current report: SEC Accession No. 0001193125-26-245636 Filing Date 2026-05-29 Accepted 2026-05-28 18:12:37 Documents 9 Period of Report 2026-05-28 Items Item 5.07: Submission of Matters to a Vote of Security Holders Interactive Data Document Format Files Seq Description Document Type Size 1 8-K rani-20260528.htm iXBRL 8-K 59018 Complete submission text file 0001193125-26-245636.txt 169227 Data Files Seq Description Document Type Size 2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rani-20260528.xsd EX-101.SCH 26034 12 EXTRACTED XBRL INSTANCE DOCUMENT rani-20260528_htm.xml XML 4939 Mailing Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131 Business Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131 (408) 457-3700 Rani Therapeutics Holdings, Inc. (Filer) CIK: 0001856725 (see all company filings) EIN.: 000000000 | State of Incorp.: CA | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-40672 | Film No.: 261038256 SIC: 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)